SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001104659-24-051210
Filing Date
2024-04-24
Accepted
2024-04-24 16:00:56
Documents
15

Document Format Files

Seq Description Document Type Size
1 424B3 tm2412594-1_424b3.htm 424B3 586681
2 GRAPHIC lg_addextherapeutics-4c.jpg GRAPHIC 13180
3 GRAPHIC fc_external-4clr.jpg GRAPHIC 35121
4 GRAPHIC fc_internal-4clr.jpg GRAPHIC 41610
5 GRAPHIC fc_research-4clr.jpg GRAPHIC 46178
6 GRAPHIC bc_mtep-4clr.jpg GRAPHIC 60463
7 GRAPHIC bc_restore-4clr.jpg GRAPHIC 37085
8 GRAPHIC lc_pharmacokinetic-4clr.jpg GRAPHIC 114449
9 GRAPHIC bc_clinicdesign-4clr.jpg GRAPHIC 43581
10 GRAPHIC tb_dosing-4clr.jpg GRAPHIC 32460
11 GRAPHIC lc_peakaims-4clr.jpg GRAPHIC 28295
12 GRAPHIC bc_pdlid-4clr.jpg GRAPHIC 33157
13 GRAPHIC bc_lid-4clr.jpg GRAPHIC 46584
14 GRAPHIC mc_baseline-4clr.jpg GRAPHIC 67610
15 GRAPHIC mc_week-4clr.jpg GRAPHIC 66537
  Complete submission text file 0001104659-24-051210.txt   1490234
Mailing Address CHEMIN DES MINES 9 GENEVA V8 CH-1202
Business Address CHEMIN DES MINES 9 GENEVA V8 CH-1202 01141228841555
Addex Therapeutics Ltd. (Filer) CIK: 0001574232 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-271611 | Film No.: 24870481
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)